GENOMIC VISION: FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2019

Financial visibility secured beyond the upcoming 12 months thanks to the refinancing operation concluded with Winance.

Updated 2 years ago
Valoe Has Agreed on 5,000,000€ Financial Arrangement with Winance.

Updated 3 years ago
Genomic Vision Announces New Financing Line with Winance, Subject to Prior Approval of the Company’s Shareholders

Updated 3 years ago
ISSUE OF THE FINAL CONVERTIBLE NOTES AND WARRANTS PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND WINANCE DISCLOSED ON 22 APRIL 2020.

Updated 3 years ago
Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants for €2 million,